Moderna Company & Staff Insights

Founder(s)

• Derrick Rossi (creator)
• Timothy A. Springer (investor)
• Robert S. Langer (investor)
• Kenneth R. Chien (investor)
• Noubar Afeyan (investor)
• Flagship Pioneering (investor)

CEO (Chief Executive Officer)

• Stephane Bancel

Launch Date

• September 2010

Moderna Country of Origin / Headquarters

• USA

Is Moderna publicly traded?

• Yes. In December 2018, Moderna conducted the largest biotech initial public offering (IPO) in history, raising US$600 million for 8% of its shares, implying a valuation of $7.5 billion; from inception to IPO, Moderna reported cumulative losses $1.5 billion and had raised $3.2 billion in equity. As of November 2020, Moderna was valued at $35 billion, and while none of its drugs had been approved, its COVID-19 vaccine, mRNA-1273, was submitted for emergency use authorization.

Old Name

• Formerly: ModeRNA Therapeutics (2010-2018)

Stock

• NASDAQ: MRNA

Website URL

• www.ModernaTX.com

What is Moderna? What does Moderna do (Idea)?

• Moderna is an American biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA).
• Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.

Searched topics related to Moderna (mostly covered in Moderna Company Analysis)

• moderna stock
• vaccine
• corona vaccine
• covid-19 vaccine
• vaccine moderna
• moderna stock price
• moderna covid
• moderna news
• pfizer
• moderna coronavirus
• moderna covid vaccine
• covid vaccine
• tesla stock
• moderna vaccine stock
• pfizer stock
• novavax
• moderna coronavirus vaccine
• coronavirus vaccine
• moderna stock today
• apple stock
• moderna stocks
• novavax stock
• stocks
• stock news
• inovio
• moderna stock news
• inovio stock
• ino
• ino stock
• moderna covid 19 vaccine
• moderna vaccine trial
• covid 19 vaccine
• fauci
• fauci moderna
• nio stock
• trump moderna
• astrazeneca stock
• nvax
• moderna vaccine
• moderna news
• who owns moderna

This document is generated by AI software and can be useful for a variety of purposes, such as:

• Journalists looking to write a piece on a company, or have an interview with its CEO, manager, or another employee.
• VCs & Angel Investors can use this insight to hunt new ventures and potential startups to fund them, also they can use it for due diligence process
• Podcast Hosts get to know their next guest, or find out who to invite from a company, or even know a company better before they comment on it.
• Sales Specialists use this analysis to know their target company or future client, and contact them wisely. Also it’s important to know who is a better prospect to contact with inside the organization.
• Legal Specialists
• Insurance Companies
• Business Bloggers
• Reporters
• B2B SaaS Startups
• Online Magazines
• Any person or company that needs insight on another company and/or its employees, managers, c-level staff, etc.